Ono Pharmaceutical - More Bad News As Tecentriq's OAK Trial Goes Well
Roche's US subsidiary, Genentech announced that the OAK trial for Tecentriq met its primary endpoint (a statistically significant and clinically...
223 Views
Japan Pharma Hits 52 Week Low
The Topix pharmaceutical index (TPPHRM) fell to 2,355 just after the lunch break in Tokyo on Friday 19th August, before recovering to 2,377, with...
195 Views
JAPAN FLOW III: The Mechanics of BOJ Buying
This is the latest in a series of JAPAN FLOW regarding recent and forward flow dynamics of Japan equities.The first two are: JAPAN FLOW I: The...
340 Views
A 'heads Up' on Changing World Heights
A comprehensive world survey of population heights over the last century has thrown up some surprising results. Americans have had the smallest...
169 Views
Opdivo Fails NSCLC Test
Ono Pharmaceutical's US partner, Bristol Myers Squibb reported that Opdivo didn’t meet its primary goal of lengthening progression-free survival in...
168 Views